| Constance J Dine, MD | |
|
3400 Civic Center Boulevard, West Pavilion-1st Floor, Philadelphia, PA 19104-4306 | |
| (215) 662-3202 | |
| (215) 349-8432 |
| Full Name | Constance J Dine |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 22 Years |
| Location | 3400 Civic Center Boulevard, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417010026 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD425693 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Penn Presbyterian Medical Center | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Penn - Medical Group | 6204730955 | 3031 |
News Archive
Rigel Pharmaceuticals, Inc. has been named one of the recipients of the 2010 Innovators Award of Excellence by the San Mateo County Economic Development Association. The award will be presented at the association's Innovators luncheon today at the Oracle Conference Center in Redwood City.
The California Institute for Regenerative Medicine's Independent Citizens' Oversight Committee on Friday announced the approval of the first human embryonic stem cell research grants provided under Proposition 71, the San Francisco Chronicle reports.
During the National Governors Association meeting on Saturday, "broad-stroke policy decisions" will be discussed — in terms of what states need to know to set up an exchange in the face of tight budgets. Meanwhile, a new AARP report concludes that consumers will have an easier time in these marketplaces if they don't have too many options.
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF™ system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
A large international study led by University of Melbourne researchers has identified a mutation linked to breast cancer attached to the newly identified gene, called XRCC2. Lead researcher Melissa Southey said the discovery, using high-speed technology, would hopefully mean that more gene mutations responsible for causing breast cancer could be rapidly identified in the next few years.
› Verified 5 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003923707 PECOS PAC ID: 6204730955 Enrollment ID: O20141216000111 |
News Archive
Rigel Pharmaceuticals, Inc. has been named one of the recipients of the 2010 Innovators Award of Excellence by the San Mateo County Economic Development Association. The award will be presented at the association's Innovators luncheon today at the Oracle Conference Center in Redwood City.
The California Institute for Regenerative Medicine's Independent Citizens' Oversight Committee on Friday announced the approval of the first human embryonic stem cell research grants provided under Proposition 71, the San Francisco Chronicle reports.
During the National Governors Association meeting on Saturday, "broad-stroke policy decisions" will be discussed — in terms of what states need to know to set up an exchange in the face of tight budgets. Meanwhile, a new AARP report concludes that consumers will have an easier time in these marketplaces if they don't have too many options.
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF™ system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
A large international study led by University of Melbourne researchers has identified a mutation linked to breast cancer attached to the newly identified gene, called XRCC2. Lead researcher Melissa Southey said the discovery, using high-speed technology, would hopefully mean that more gene mutations responsible for causing breast cancer could be rapidly identified in the next few years.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Constance J Dine, MD 3400 Civic Center Boulevard, West Pavilion-1st Floor, Philadelphia, PA 19104-4306 Ph: (215) 662-3202 | Constance J Dine, MD 3400 Civic Center Boulevard, West Pavilion-1st Floor, Philadelphia, PA 19104-4306 Ph: (215) 662-3202 |
News Archive
Rigel Pharmaceuticals, Inc. has been named one of the recipients of the 2010 Innovators Award of Excellence by the San Mateo County Economic Development Association. The award will be presented at the association's Innovators luncheon today at the Oracle Conference Center in Redwood City.
The California Institute for Regenerative Medicine's Independent Citizens' Oversight Committee on Friday announced the approval of the first human embryonic stem cell research grants provided under Proposition 71, the San Francisco Chronicle reports.
During the National Governors Association meeting on Saturday, "broad-stroke policy decisions" will be discussed — in terms of what states need to know to set up an exchange in the face of tight budgets. Meanwhile, a new AARP report concludes that consumers will have an easier time in these marketplaces if they don't have too many options.
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF™ system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
A large international study led by University of Melbourne researchers has identified a mutation linked to breast cancer attached to the newly identified gene, called XRCC2. Lead researcher Melissa Southey said the discovery, using high-speed technology, would hopefully mean that more gene mutations responsible for causing breast cancer could be rapidly identified in the next few years.
› Verified 5 days ago
Philippe Olivier Szapary, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3400 Civic Center Blvd, East Pavilion, 2nd Floor, Philadelphia, PA 19104 Phone: 215-615-4949 | |
Dr. Jamie L. Garfield, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-5864 Fax: 215-707-6867 | |
Maria Esther Escorcia De Leon, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-1622 Fax: 215-707-0943 | |
Cherag Daruwala, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2301 E Allegheny Ave, Suite 190b, Philadelphia, PA 19134 Phone: 215-926-3120 Fax: 215-926-3123 | |
Dr. Robert Burke, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 51 N 39th St, Philadelphia, PA 19104 Phone: 215-662-9436 Fax: 215-243-3208 | |
Eva Hassan Alsheik, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 219 N Broad St, 5th Floor, Philadelphia, PA 19107 Phone: 215-762-6071 | |
Dr. Jason Thomas Ackrivo, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-614-0871 |